High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.

Source:http://linkedlifedata.com/resource/pubmed/id/7523609

Download in:

View as

General Info

PMID
7523609